Dr. Bernard Fiifi Brakatu

 PC: rash, general weakness, multiple sores,
insomnia – 6/12
 HPC: Pt had been well until the Sxx began and
progressed gradually until she presented at the
hospital
 ODQ: Wt loss+, Easy fatigability+, dizzinesso
 SE: cougho, chest paino, palpitationso,
dysphagia+(with solid food), odynophagia+,
vomitingo, diarrheao, dysuriao, frequencyo,
headacheo

 PMH – HPTo, DMo
 DH – Nil of note
 SH – Trader, ROHo, Smokingo
Hx

 Chronically ill middle-aged woman with generalized
hyperpigmentation of the skin
 Po, Jo, Fo, Hyd-sat, Pedal Edema+, Facial puffiness+
 CVS – S1S2Mo PR 90bpm RGV, BP 130/80mmHg
 Chest – clinically clear
 CNS – Fully conscious and alert
 S/L- Generalized Rash with Multiple ulcers at the
gluteal region and at the groin
O/E

?SLE
?RVI
Diagnosis

 Admit to GFW
 FBC, BUE/Cr, LFTs, VCT, ANA, Anti-dsDNA
 IVF – 1L R/L, 1L 5%Dex + Pabrinex I &II
 IV Lasix 40mg bd x 48hrs
 Fluid input/output chart
 Daily wound dressing
 Ted Stockings
 Turn regulartly in bed(12hrly)
Plan
 Day 3- Tb Flucloxacillin and Z9inc Oxide cream
added
 Day 4 – Tb Prednisolone 40mg dly x 7
 Day 6 – VCT- non-reactive, Physiotherapy
 Day 10 – dysphagia worsening; ?scleroderma
 Day 11 – abd pain; steroid-induced gastritis;
omeprazole and nugel added
 Day 12 – pt unable to elevate arms above the
head(proximal myopathy); Dermatomyositis; Tb
Azathioprine 50mg dly x 7, Tb Prednisolone 50mg
dly x 17/7, Gynae review for malignancy
 Day 12 –date – Palliative/ Physiotherapy
R

LITERATURE REVIEW

 Dermatomyositis(DM) is a rare autoimmune
disorder characterized by inflammation of striated
muscle, causing proximal muscle weakness with
skin involvement.
 NB: Polymyositis has the same clinical features but
has no skin involvement.
Definition

 Incidence is about 2-10/million population per
annum
 It occurs in all races and at all ages
 M:F ratio is 1:3
 Etiology is unknown, although viruses(e.g. Coxsackie,
rubella, influenza) have been implicated
 Persons with HLA-B8/DR3 appear to be
predisposed
Epidemiology and
Etiology

 The onset can be either insidious, spanning over
months, or acute
 General malaise, weight loss and fever can develop
in the acute phase
 There is myalgia, polyarthritis and Raynaud’s
phenomenon
 Shoulder and pelvic girdle muscles become wasted
but are not usually tender and so squatting and
climbing of stairs become difficult
 Face and distal limb muscles are not usually affected
Clinical Features

 As the disease progresses, pharyngeal, laryngeal and
respiratory muscle involvement can lead to
dysphonia and respiratory failure
 These complications are rare if the disease is treated
early.
C/F

 Distinguish DM from PM with characteristic rash
affecting the eyelids where heliotrope (purple)
discoloration is accompanied by periorbital oedema,
and the fingers where one sees purple-red raised
vasculitic patches
 These patches occur over the knuckles (Gottron’s
papules) in 70% of patients, and this appearance is
highly specific for DM
 Ulcerative vasculitis and calcinosis of the
subcutaneous tissue occurs in 25% of cases. In the
long term, muscle fibrosis and contractures of joints
occur.
C/F

Gottren’s papules

Gottren’s papules

 Pulmonary interstitial fibrosis, Raynaud’s phenom-
enon, arthritis and hardening and fissuring of skin
over the pulp surface of the fingers (mechanic’s
hands)
 Dysphagia is seen in about 50% of patients owing to
oesophageal muscle involvement.

 The relative risk of cancer is 2.4 for male and 3.4 for
female patients, and a wide variety of cancers have
been reported usually gynaecological and carcinoid
tumors
Association with
Malignancies

 Serum creatine kinase (CK), aminotransferases,
lactate dehydrogenase (LDH) and aldolase are
usually raised
 ESR and CRP may be raised.
 Serum autoantibody studies : ANA is usually
positive in people with DM. Rheumatoid factor is
present in up to 50%
 Electromyography(EMG): shows changes consistent
with myositis
Investigations

 MRI- shows abnormally inflamed muscle
 Needle muscle biopsy
 Screening for malignancy - CXR, mammography,
pelvic/abdominal ultrasound, urine microscopy and
tumor markers, PET scan

 Bed rest and physiotherapy
 Prednisolone is the mainstay of treatment – 0.5-
1.0mg/kg/body wt as initial therapy continued
until at least 1 month after myositis has become
clinically and enzymatically inactive
 Early intervention with steroid-sparing agents such
as meth- otrexate, azathioprine, ciclosporin,
cyclophosphamide and mycophenolate mofetil is
common, especially where there is clinical relapse or
rise in CK as the dose of steroids is reduced
 Taper steroids slowly
Treatment

 Intravenous immunoglobulin therapy (IVIG) is
helpful in some refractory cases
 Monoclonal antibodies such as Rituximab may be
helpful
 Counsel patient
 Review once to twice a year



Dermatomyositis

  • 1.
  • 2.
      PC: rash,general weakness, multiple sores, insomnia – 6/12  HPC: Pt had been well until the Sxx began and progressed gradually until she presented at the hospital  ODQ: Wt loss+, Easy fatigability+, dizzinesso  SE: cougho, chest paino, palpitationso, dysphagia+(with solid food), odynophagia+, vomitingo, diarrheao, dysuriao, frequencyo, headacheo
  • 3.
      PMH –HPTo, DMo  DH – Nil of note  SH – Trader, ROHo, Smokingo Hx
  • 4.
      Chronically illmiddle-aged woman with generalized hyperpigmentation of the skin  Po, Jo, Fo, Hyd-sat, Pedal Edema+, Facial puffiness+  CVS – S1S2Mo PR 90bpm RGV, BP 130/80mmHg  Chest – clinically clear  CNS – Fully conscious and alert  S/L- Generalized Rash with Multiple ulcers at the gluteal region and at the groin O/E
  • 5.
  • 6.
      Admit toGFW  FBC, BUE/Cr, LFTs, VCT, ANA, Anti-dsDNA  IVF – 1L R/L, 1L 5%Dex + Pabrinex I &II  IV Lasix 40mg bd x 48hrs  Fluid input/output chart  Daily wound dressing  Ted Stockings  Turn regulartly in bed(12hrly) Plan
  • 7.
     Day 3-Tb Flucloxacillin and Z9inc Oxide cream added  Day 4 – Tb Prednisolone 40mg dly x 7  Day 6 – VCT- non-reactive, Physiotherapy  Day 10 – dysphagia worsening; ?scleroderma  Day 11 – abd pain; steroid-induced gastritis; omeprazole and nugel added  Day 12 – pt unable to elevate arms above the head(proximal myopathy); Dermatomyositis; Tb Azathioprine 50mg dly x 7, Tb Prednisolone 50mg dly x 17/7, Gynae review for malignancy  Day 12 –date – Palliative/ Physiotherapy R
  • 8.
  • 9.
      Dermatomyositis(DM) isa rare autoimmune disorder characterized by inflammation of striated muscle, causing proximal muscle weakness with skin involvement.  NB: Polymyositis has the same clinical features but has no skin involvement. Definition
  • 10.
      Incidence isabout 2-10/million population per annum  It occurs in all races and at all ages  M:F ratio is 1:3  Etiology is unknown, although viruses(e.g. Coxsackie, rubella, influenza) have been implicated  Persons with HLA-B8/DR3 appear to be predisposed Epidemiology and Etiology
  • 11.
      The onsetcan be either insidious, spanning over months, or acute  General malaise, weight loss and fever can develop in the acute phase  There is myalgia, polyarthritis and Raynaud’s phenomenon  Shoulder and pelvic girdle muscles become wasted but are not usually tender and so squatting and climbing of stairs become difficult  Face and distal limb muscles are not usually affected Clinical Features
  • 12.
      As thedisease progresses, pharyngeal, laryngeal and respiratory muscle involvement can lead to dysphonia and respiratory failure  These complications are rare if the disease is treated early. C/F
  • 13.
      Distinguish DMfrom PM with characteristic rash affecting the eyelids where heliotrope (purple) discoloration is accompanied by periorbital oedema, and the fingers where one sees purple-red raised vasculitic patches  These patches occur over the knuckles (Gottron’s papules) in 70% of patients, and this appearance is highly specific for DM  Ulcerative vasculitis and calcinosis of the subcutaneous tissue occurs in 25% of cases. In the long term, muscle fibrosis and contractures of joints occur. C/F
  • 14.
  • 15.
  • 16.
      Pulmonary interstitialfibrosis, Raynaud’s phenom- enon, arthritis and hardening and fissuring of skin over the pulp surface of the fingers (mechanic’s hands)  Dysphagia is seen in about 50% of patients owing to oesophageal muscle involvement.
  • 17.
      The relativerisk of cancer is 2.4 for male and 3.4 for female patients, and a wide variety of cancers have been reported usually gynaecological and carcinoid tumors Association with Malignancies
  • 18.
      Serum creatinekinase (CK), aminotransferases, lactate dehydrogenase (LDH) and aldolase are usually raised  ESR and CRP may be raised.  Serum autoantibody studies : ANA is usually positive in people with DM. Rheumatoid factor is present in up to 50%  Electromyography(EMG): shows changes consistent with myositis Investigations
  • 19.
      MRI- showsabnormally inflamed muscle  Needle muscle biopsy  Screening for malignancy - CXR, mammography, pelvic/abdominal ultrasound, urine microscopy and tumor markers, PET scan
  • 20.
      Bed restand physiotherapy  Prednisolone is the mainstay of treatment – 0.5- 1.0mg/kg/body wt as initial therapy continued until at least 1 month after myositis has become clinically and enzymatically inactive  Early intervention with steroid-sparing agents such as meth- otrexate, azathioprine, ciclosporin, cyclophosphamide and mycophenolate mofetil is common, especially where there is clinical relapse or rise in CK as the dose of steroids is reduced  Taper steroids slowly Treatment
  • 21.
      Intravenous immunoglobulintherapy (IVIG) is helpful in some refractory cases  Monoclonal antibodies such as Rituximab may be helpful  Counsel patient  Review once to twice a year
  • 22.
  • 23.